{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:36:48Z","timestamp":1760189808078,"version":"3.40.5"},"reference-count":87,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:p>The majority of patients with coronavirus disease 2019 will have mild or asymptomatic disease, however, obstetric patients are uniquely at risk for disease progression and adverse outcomes. Preventive strategies including masking, physical distancing, vaccination, and chemoprophylaxis have been well studied, are critical to disease mitigation, and can be used in the pregnant population. High-quality data are needed to assess safety and effectiveness of therapeutics and vaccination in pregnancy, as well as long-term data on maternal and newborn outcomes.<\/jats:p>","DOI":"10.1097\/grf.0000000000000670","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T20:00:45Z","timestamp":1642622445000},"page":"161-178","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Obstetric Outpatient Management During the COVID-19 Pandemic: Prevention, Treatment of Mild Disease, and Vaccination"],"prefix":"10.1097","volume":"65","author":[{"given":"NAIMA T.","family":"JOSEPH","sequence":"first","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EMILY S.","family":"MILLER","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"key":"R2-20250512","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)","volume":"20","author":"Dong","year":"2020","journal-title":"Lancet Inf Dis"},{"key":"R3-20250512","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.aivir.2018.01.001","article-title":"Hosts and sources of endemic human coronaviruses","volume":"100","author":"Corman","year":"2018","journal-title":"Adv Virus Res"},{"key":"R4-20250512","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R5-20250512","doi-asserted-by":"crossref","first-page":"e0230295","DOI":"10.1371\/journal.pone.0230295","article-title":"The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study","volume":"15","author":"Li","year":"2020","journal-title":"PLoS One"},{"key":"R6-20250512","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"key":"R9-20250512","doi-asserted-by":"crossref","first-page":"655","DOI":"10.7326\/M20-6976","article-title":"The proportion of SARS-CoV-2 infections that are asymptomatic: a systematic review","volume":"174","author":"Oran","year":"2021","journal-title":"Ann Intern Med"},{"key":"R10-20250512","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMc2013020","article-title":"Natural history of asymptomatic SARS-CoV-2 infection","volume":"383","author":"Sakurai","year":"2020","journal-title":"N Engl J Med"},{"key":"R11-20250512","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMcp2009249","article-title":"Mild or moderate COVID-19","volume":"383","author":"Gandhi","year":"2020","journal-title":"N Engl J Med"},{"key":"R12-20250512","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/AOG.0000000000003983","article-title":"Clinical implications of universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing in pregnancy","volume":"136","author":"Miller","year":"2020","journal-title":"Obs Gynecol"},{"key":"R13-20250512","doi-asserted-by":"crossref","first-page":"769","DOI":"10.15585\/mmwr.mm6925a1","article-title":"Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status\u2014United States, January 22\u2013June 7, 2020","volume":"69","author":"Ellington","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R14-20250512","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ajog.2020.07.045","article-title":"Are clinical outcomes worse for pregnant women at \u226520 weeks\u2019 gestation infected with coronavirus disease 2019? A multicenter case-control study with propensity score matching","volume":"223","author":"Badr","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R15-20250512","doi-asserted-by":"crossref","first-page":"m2107","DOI":"10.1136\/bmj.m2107","article-title":"Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study","volume":"369","author":"Knight","year":"2020","journal-title":"BMJ"},{"key":"R16-20250512","doi-asserted-by":"crossref","first-page":"ofaa294","DOI":"10.1093\/ofid\/ofaa294","article-title":"Clinical characteristics of pregnant women with coronavirus disease 2019 in Wuhan, China","volume":"7","author":"Cheng","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"R17-20250512","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/AOG.0000000000004178","article-title":"Clinical presentation of coronavirus disease 2019 (COVID-19) in pregnant and recently pregnant people","volume":"136","author":"Afshar","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R18-20250512","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2196\/19642","article-title":"Clinical characteristics and outcomes of childbearing-age women with COVID-19 in Wuhan: Retrospective, single-center study","volume":"22","author":"Wei","year":"2020","journal-title":"J Med Internet Res"},{"key":"R19-20250512","doi-asserted-by":"crossref","first-page":"993","DOI":"10.15585\/mmwr.mm6930e1","article-title":"Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a Multistate Health Care Systems Network\u2014United States, March\u2013June 2020","volume":"69","author":"Tenforde","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R20-20250512","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.15585\/mmwr.mm6944e3","article-title":"Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status\u2014United States, January 22\u2013October 3, 2020","volume":"69","author":"Zambrano","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R21-20250512","doi-asserted-by":"crossref","first-page":"eaan2946","DOI":"10.1126\/sciimmunol.aan2946","article-title":"An immune clock of human pregnancy","volume":"2","author":"Aghaeepour","year":"2017","journal-title":"Sci Immunol"},{"key":"R22-20250512","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccm.2010.11.001","article-title":"Respiratory physiology in pregnancy","volume":"32","author":"Hegewald","year":"2011","journal-title":"Clin Chest Med"},{"key":"R23-20250512","first-page":"1","article-title":"Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: The INTERCOVID Multinational Cohort Study","volume":"e211050","author":"Villar","year":"2021","journal-title":"JAMA Pediatr"},{"key":"R24-20250512","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1001\/jama.2021.5775","article-title":"Association of maternal SARS-CoV-2 infection in pregnancy with neonatal outcomes","volume":"325","author":"Norman","year":"2021","journal-title":"J Am Med Assoc"},{"key":"R25-20250512","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/AOG.0000000000004339","article-title":"Disease severity and perinatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19)","volume":"137","author":"Metz","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R26-20250512","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/uog.23619","article-title":"Pregnancy and neonatal outcomes of COVID-19: coreporting of common outcomes from PAN-COVID and AAP-SONPM registries","volume":"57","author":"Mullins","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R27-20250512","doi-asserted-by":"crossref","first-page":"E647","DOI":"10.1503\/cmaj.200821","article-title":"Probable congenital SARS-CoV-2 infection in a neonate born to a woman with active SARS-CoV-2 infection","volume":"192","author":"Kirtsman","year":"2020","journal-title":"Can Med Assoc J"},{"key":"R28-20250512","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1038\/s41467-020-17436-6","article-title":"Transplacental transmission of SARS-CoV-2 infection","volume":"11","author":"Vivanti","year":"2020","journal-title":"Nat Commun"},{"key":"R29-20250512","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1055\/s-0040-1710050","article-title":"Severe COVID-19 during pregnancy and possible vertical transmission","volume":"37","author":"Alzamora","year":"2020","journal-title":"Am J Perinatol"},{"key":"R30-20250512","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ajcp\/aqaa089","article-title":"Placental pathology in COVID-19","volume":"154","author":"Shanes","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"R31-20250512","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000511324","article-title":"Placental pathology findings during and after SARS-CoV-2 infection: features of villitis and malperfusion","volume":"88","author":"Menter","year":"2021","journal-title":"Pathobiology"},{"key":"R32-20250512","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/AOG.0000000000000480","article-title":"The maternal early warning criteria: a proposal from the National Partnership for Maternal Safety","volume":"124","author":"Mhyre","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R33-20250512","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41591-020-01202-8","article-title":"Immune determinants of COVID-19 disease presentation and severity","volume":"27","author":"Brodin","year":"2021","journal-title":"Nat Med"},{"key":"R34-20250512","doi-asserted-by":"crossref","first-page":"73.e1","DOI":"10.1016\/j.ajog.2021.01.016","article-title":"SARS-CoV-2 serology levels in pregnant women and their neonates","volume":"225","author":"Kubiak","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R35-20250512","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/AOG.0000000000004440","article-title":"Maternal antibody response, neutralizing potency, and placental antibody transfer after severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection","volume":"138","author":"Joseph","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R36-20250512","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.2147\/IDR.S264541","article-title":"Clinico-radiological features and outcomes in pregnant women with COVID-19 pneumonia compared with age-matched non-pregnant women","volume":"13","author":"Liu","year":"2020","journal-title":"Infect Drug Resist"},{"key":"R39-20250512","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72\u202f314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"R40-20250512","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/AOG.0000000000003979","article-title":"Clinical findings and disease severity in hospitalized pregnant women with coronavirus disease 2019 (COVID-19)","volume":"136","author":"Savasi","year":"2020","journal-title":"Obs Gynecol"},{"key":"R41-20250512","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1055\/s-0040-1712164","article-title":"The relationship between status at presentation and outcomes among pregnant women with COVID-19","volume":"37","author":"London","year":"2020","journal-title":"Am J Perinatol"},{"key":"R42-20250512","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/AOG.0000000000003996","article-title":"Symptoms and critical illness among obstetric patients with coronavirus disease 2019 (COVID-19) infection","volume":"136","author":"Andrikopoulou","year":"2020","journal-title":"Obstet Gynecol"},{"journal-title":"Am J Obstet Gynecol","article-title":"Outpatient Assessment and Management for Pregnant Women With Suspected or Confirmed Novel Coronavirus (COVID-19)","year":"2020","key":"R43-20250512"},{"key":"R45-20250512","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa2029849","article-title":"SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with COVID-19","volume":"384","author":"Chen","year":"2021","journal-title":"N Engl J Med"},{"key":"R46-20250512","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jama.2021.0202","article-title":"Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: a randomized clinical trial","volume":"325","author":"Gottlieb","year":"2021","journal-title":"JAMA"},{"key":"R47-20250512","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa2035002","article-title":"REGN-COV2, a neutralizing antibody cocktail, in outpatients with COVID-19","volume":"384","author":"Weinreich","year":"2021","journal-title":"N Engl J Med"},{"key":"R49-20250512","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","volume":"593","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"R50-20250512","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/jth.14849","article-title":"Thromboinflammation and the hypercoagulability of COVID-19","volume":"18","author":"Connors","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R51-20250512","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/jama.2020.13372","article-title":"Thrombosis in hospitalized patients with COVID-19 in a New York City Health System","volume":"324","author":"Bilaloglu","year":"2020","journal-title":"JAMA"},{"key":"R52-20250512","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"key":"R53-20250512","doi-asserted-by":"crossref","first-page":"e2029256","DOI":"10.1001\/jamanetworkopen.2020.29256","article-title":"Pregnancy outcomes among women with and without severe acute respiratory syndrome coronavirus 2 infection","volume":"3","author":"Adhikari","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R55-20250512","doi-asserted-by":"crossref","first-page":"389.e1","DOI":"10.1016\/j.ajog.2020.05.029","article-title":"Prenatal care redesign: creating flexible maternity care models through virtual care","volume":"223","author":"Peahl","year":"2020","journal-title":"Am J Obs Gynecol"},{"key":"R56-20250512","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1515\/jpm-2020-0182","article-title":"Effects of coronavirus 19 pandemic on maternal anxiety during pregnancy: a prospectic observational study","volume":"48","author":"Mappa","year":"2020","journal-title":"J Perinat Med"},{"key":"R57-20250512","doi-asserted-by":"crossref","first-page":"240.e1","DOI":"10.1016\/j.ajog.2020.05.009","article-title":"Perinatal depressive and anxiety symptoms of pregnant women during the coronavirus disease 2019 outbreak in China","volume":"223","author":"Wu","year":"2020","journal-title":"Am J Obs Gynecol"},{"key":"R58-20250512","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1515\/jpm-2020-0208","article-title":"Prenatal screening diagnosis and management in the era of coronavirus: the Sardinian experience","volume":"48","author":"Monni","year":"2020","journal-title":"J Perinat Med"},{"key":"R59-20250512","article-title":"The effect of COVID-19 pandemic and social restrictions on depression rates and maternal attachment in immediate postpartum women: a preliminary study","author":"Oskovi-Kaplan","year":"2020","journal-title":"Psychiatr Q"},{"key":"R60-20250512","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1080\/14767058.2020.1815190","article-title":"Effect of COVID-19 pandemic process on prenatal diagnostic procedures","volume":"34","author":"Ozalp","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R61-20250512","doi-asserted-by":"crossref","first-page":"e1116","DOI":"10.1016\/S2214-109X(20)30319-3","article-title":"COVID-19 outbreak and decreased hospitalisation of pregnant women in labour","volume":"8","author":"Kumari","year":"2020","journal-title":"Lancet Glob Heal"},{"key":"R62-20250512","first-page":"533","article-title":"Lockdown with a price: the impact of the COVID-19 pandemic on prenatal care and perinatal outcomes in a Tertiary Care Center","volume":"9","author":"Justman","year":"2020","journal-title":"Isr Med Assoc J"},{"key":"R63-20250512","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejogrb.2020.04.022","article-title":"Health anxiety and behavioural changes of pregnant women during the COVID-19 pandemic","volume":"249","author":"Corbett","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R64-20250512","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/AOG.0000000000004088","article-title":"Influence of race and ethnicity on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection rates and clinical outcomes in pregnancy","volume":"136","author":"Emeruwa","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R65-20250512","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/AOG.0000000000003933","article-title":"Examining inequities associated with changes in obstetric and gynecologic care delivery during the coronavirus disease 2019 (COVID-19) pandemic","volume":"136","author":"Onwuzurike","year":"2020","journal-title":"Obs Gynecol"},{"key":"R66-20250512","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41577-020-00451-5","article-title":"COVID-19 herd immunity: where are we?","volume":"20","author":"Fontanet","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"R67-20250512","article-title":"Coronavirus vaccine tracker","author":"Zimmer","year":"2020","journal-title":"New York Times"},{"key":"R68-20250512","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41563-020-0746-0","article-title":"Next-generation vaccine platforms for COVID-19","volume":"19","author":"Van Riel","year":"2020","journal-title":"Nat Mater"},{"key":"R69-20250512","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1001\/jama.2018.0345","article-title":"Novel vaccine technologies: essential components of an adequate response to emerging viral diseases","volume":"319","author":"Graham","year":"2018","journal-title":"JAMA"},{"key":"R70-20250512","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"R71-20250512","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"R72-20250512","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1038\/s41467-021-24285-4","article-title":"COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants","volume":"12","author":"Jalkanen","year":"2021","journal-title":"Nat Commun"},{"key":"R73-20250512","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-021-03693-y","article-title":"BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants","volume":"596","author":"Liu","year":"2021","journal-title":"Nature"},{"key":"R74-20250512","article-title":"Serum neutralizing activity of mRNA-1273 against SARS-CoV-2 variants","author":"Choi","year":"2021","journal-title":"bioRxiv"},{"key":"R75-20250512","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.15585\/mmwr.mm6950e2","article-title":"The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine\u2014United States, Decmeber 2020","volume":"69","author":"Oliver","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R76-20250512","doi-asserted-by":"crossref","first-page":"749","DOI":"10.15585\/mmwr.mm7020e1","article-title":"The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12\u201315 years\u2014United States, May 2021","volume":"70","author":"Wallace","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R77-20250512","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.15585\/mmwr.mm695152e1","article-title":"The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Moderna-19 Vaccine\u2014United States, December 2020","volume":"69","author":"Oliver","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R78-20250512","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa2034201","article-title":"Interim results of a phase 1\u20132a trial of Ad26.COV2.S COVID-19 vaccine","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"key":"R79-20250512","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"key":"R80-20250512","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-021-03681-2","article-title":"Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans","volume":"596","author":"Alter","year":"2021","journal-title":"Nature"},{"key":"R81-20250512","doi-asserted-by":"crossref","first-page":"329","DOI":"10.15585\/mmwr.mm7009e4","article-title":"The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Janssen COVID-19 Vaccine\u2014United States, February 2021","volume":"70","author":"Oliver","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R82-20250512","doi-asserted-by":"crossref","first-page":"651","DOI":"10.15585\/mmwr.mm7017e4","article-title":"Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients\u2014United States, April 2021","volume":"70","author":"MacNeil","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R83-20250512","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2020","journal-title":"Lancet"},{"key":"R84-20250512","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1056\/NEJMoa2107659","article-title":"Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine","volume":"385","author":"Heath","year":"2021","journal-title":"N Engl J Med"},{"key":"R85-20250512","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.vaccine.2019.01.011","article-title":"Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response","volume":"39","author":"Krubiner","year":"2021","journal-title":"Vaccine"},{"key":"R89-20250512","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.reprotox.2021.05.007","article-title":"Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine","volume":"103","author":"Bowman","year":"2021","journal-title":"Reprod Toxicol"},{"key":"R90-20250512","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1473-3099(20)30016-5","article-title":"Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial","volume":"20","author":"Tapia","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"R91-20250512","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3201\/eid2603.191018","article-title":"Pregnancy outcomes among women receiving rVSV\u0394-ZEBOV-GP ebola vaccine during the sierra leone trial to introduce a vaccine against ebola","volume":"26","author":"Legardy-Williams","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"R92-20250512","doi-asserted-by":"crossref","first-page":"895","DOI":"10.15585\/mmwr.mm7024e2","article-title":"COVID-19 vaccination coverage among pregnant women during pregnancy \u2014 Eight Integrated Health Care Organizations, United States, December 14, 2020\u2013May 8, 2021","volume":"70","author":"Razzaghi","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R93-20250512","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","article-title":"Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons","volume":"384","author":"Shimabukuro","year":"2021","journal-title":"N Engl J Med"},{"key":"R94-20250512","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/AOG.0000000000004457","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in pregnancy: measures of immunity and placental histopathology","volume":"138","author":"Shanes","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R95-20250512","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.2021.7563","article-title":"Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women","volume":"325","author":"Collier","year":"2021","journal-title":"JAMA"},{"key":"R96-20250512","doi-asserted-by":"crossref","first-page":"303.e1","DOI":"10.1016\/j.ajog.2021.03.023","article-title":"COVID-19 vaccine response in pregnant and lactating women: a cohort study","volume":"225","author":"Gray","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R97-20250512","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/AOG.0000000000004438","article-title":"Antibody response to coronavirus disease 2019 (COVID-19) messenger RNA vaccination in pregnant women and transplacental passage into cord blood","volume":"138","author":"Prabhu","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R98-20250512","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/AOG.0000000000004290","article-title":"Coronavirus disease 2019 (COVID-19) vaccines and pregnancy: what obstetricians need to know","volume":"137","author":"Rasmussen","year":"2021","journal-title":"Obstet Gynecol"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000670","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T15:17:52Z","timestamp":1747063072000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000670","relation":{},"ISSN":["0009-9201"],"issn-type":[{"type":"print","value":"0009-9201"}],"subject":[],"published":{"date-parts":[[2022,1,20]]}}}